Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-10-Speech-1-247-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20120910.29.1-247-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Madam President, Commissioner, I would, of course, like to join everyone in welcoming the Commission’s response to the tragic case of the Mediator drug, proposing greater informational obligations for Member States when withdrawing drugs from the market, and strengthening the coordinating role of the European Medicines Agency.
There is some doubt, of course, as to whether this informational obligation also applies to third countries outside the EU. I also support publication of the reasons for a refusal to authorise the placing of medicines on the market. This is all well and good. I would also, of course, like to call on the Commission to analyse the impact of European legislation on other areas when it discovers problems in Member States, and to propose amendments in a prompt and timely manner.
I would like to mention as an example fraudulent mail order businesses, in relation to which the Commission is still unable to rectify matters, despite petitions from European citizens, and interventions and resolutions of the European Parliament.
Another example might be the issue that has dragged on for over three years in relation to the Canadian visa requirement for Czech citizens."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples